Lung transplant after 6 months on ECMO support for SARS-CoV-2-induced ARDS complicated by severe antibody-mediated rejection
Guardado en:
Autores principales: | Johan Nilsson, Per Ederoth, Lennart Hansson, Sandra Lindstedt, Edgar Grins, Hillevi Larsson, Hamid Akbarshahi, Iran Silva, Snejana Hyllen, Darcy Wagner, Johan Sjögren, Ronny Gustafsson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b2549d68502248a294ed20371d675e86 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tracheobronchoplasty and Diaphragmatic Plication under VV ECMO for Combined ECAC and Diaphragmatic Paralysis
por: Mehmet M. Tatari, et al.
Publicado: (2021) -
Surgical pulmonary embolectomy on VA-ECMO
por: Rachel Steinhorn, et al.
Publicado: (2021) -
Exogenous pulmonary surfactant in COVID-19 ARDS. The similarities to neonatal RDS suggest a new scenario for an ‘old’ strategy
por: Massimo Girardis, et al.
Publicado: (2021) -
Impact of obesity on survival in COVID-19 ARDS patients receiving ECMO: results from an ambispective observational cohort
por: Florence Daviet, et al.
Publicado: (2021) -
Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)
por: Seyed MohammadReza Hashemian, et al.
Publicado: (2021)